Patent ID: 11857543
Assignee: AKEBIA THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 9:
10. The method of claim 1, wherein hemoglobin levels of the patient
a. are maintained at a level of at least about 9.0 g/dL and at or below about 13.0 g/dL; or
b. are maintained at a level of at least about 10.0 g/dL and at or below about 13.0 g/dL; or
c. are maintained at a level of at least about 11.0 g/dL and at or below about 13.0 g/dL; or
d. are increased by at least about 1.2 g/dL relative to a baseline hemoglobin level.